Early NT-proBNP is able to predict spontaneous closure of patent ductus arteriosus in preterm neonates, but not the need of its treatment

Pediatric Cardiology

Volumn 32, Issue 7, 2011, Pages 953-957

  Martinovici, D ^a   Vanden Eijnden, S ^a   Unger, P ^a   Najem, B ^a   Gulbis, B ^a   Marechal Y ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

NT proBNP; PDA; Preterm

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER; IBUPROFEN; BRAIN NATRIURETIC PEPTIDE; PEPTIDE FRAGMENT; PRO BRAIN NATRIURETIC PEPTIDE (1 76); PRO-BRAIN NATRIURETIC PEPTIDE (1-76); PROTEIN PRECURSOR;

ARTICLE; ASPHYXIA; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONGENITAL MALFORMATION; CONTROLLED STUDY; ECHOCARDIOGRAPHY; EXTREMELY LOW BIRTH WEIGHT; GESTATIONAL AGE; HUMAN; NEWBORN; NEWBORN INTENSIVE CARE; PATENT DUCTUS ARTERIOSUS; PERSISTENT PULMONARY HYPERTENSION; PREDICTIVE VALUE; PREMATURITY; PROTEIN BLOOD LEVEL; SINGLE BLIND PROCEDURE; VERY LOW BIRTH WEIGHT; BLOOD; BODY WEIGHT; COMPARATIVE STUDY; EARLY DIAGNOSIS; ECHOGRAPHY; FOLLOW UP; HOSPITALIZATION; PATHOPHYSIOLOGY; PROGNOSIS; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; REMISSION; TIME;

BODY WEIGHT; DUCTUS ARTERIOSUS, PATENT; EARLY DIAGNOSIS; ECHOCARDIOGRAPHY; FOLLOW-UP STUDIES; HUMANS; INFANT, NEWBORN; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; PREMATURE BIRTH; PROGNOSIS; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; REMISSION, SPONTANEOUS; ROC CURVE; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 84859640528     PISSN: 01720643     EISSN: 14321971     Source Type: Journal    
DOI: 10.1007/s00246-011-0020-y     Document Type: Article

References (19)

1. Attridge JT, Kaufman DA, Lim DS (2009) B-Type natriuretic peptide concentrations to guide treatment of patent ductus arteriosus. Arch Dis Child Fetal Neonatal Ed 94:F178-F182
2. Benitz WE (2010) Treatment of persistent ductus arteriosus in preterm infants: time to accept the null hypothesis? J Perinatol 30:241-252
3. Chiruvolu A, Jaleel MA (2009) Therapeutic management of patent ductus arteriosus. Early Hum Dev 85(3):151-155
4. Clyman RI (2000) Ibuprofen and patent ductus arteriosus. N Engl J Med 343(10):728-730
5. El Hajjar M, Vaksmann G, Rakza T, Kongolo G, Storme L (2005) Severity of the ductal shunt: a comparison of different markers. Arch Dis Child Fetal Neonatal Ed 90:F419-F422
6. El-Khuffash A, Davis PG, Walsh K, Molloy EJ (2008) Cardiac troponin T and N-terminal-pro-B natriuretic peptide reflect myocardial function in preterm infants. J Perinatol 28(7):482-486
7. Farombi-Oghuvbu I, Matthews T, Mayne PD, Guerin H, Corcoran JD (2008) N-Terminal pro-B-type natriuretic peptide: a measure of significant patent ductus arteriosus. Arch Dis Child Fetal Neonatal Ed 93:F257-F260
8. Fowlie PW, Davis PG, McGuire W (2010) Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants. Cochrane Database Syst Rev 7:CD000174
9. Hamrick SEG, Hansmann G (2010) Patent ductus arteriosus of the preterm infant. Pediatrics 125(5):1019-1030
10. Herrman K, Bose C, Lewis K, Laughon M (2009) Spontaneous closure of the patent ductus arteriosus in very low birth weight infants following discharge from the neonatal unit. Arch Dis Child Fetal Neonatal Ed 94(1):F48-F50
11. Keane JF, Fyler DC (2006) Patent ductus arteriosus. In: Keane JF, Lock JE, Fyler DC (eds) Nadas' pediatric cardiology, 2nd edn. Saunders/Elsevier, Philadelphia, pp 617-625
12. Koch J, Hensley G, Roy L, Brown S, Ramaciotti C, Rosenfeld CR (2006) Prevalence of spontaneous closure of the ductus arteriosus in neonates at a birth weight of 1000 grams or less. Pediatrics 117(4):1113-1121
13. Lai WW, Geva T, Shirali GS, Frommelt PC, Humes RA, Brook MM, Pignatelli RH, Rychik J, Task Force of the Pediatric Council of the American Society of Echocardiography; Pediatric Council of the American Society of Echocardiography (2006) Guidelines and standards for performance of a pediatric echocardiogram: a report from the Task Force of the Pediatric Council of the American Society of Echocardiography. J Am Soc Echocardiogr 19:1413-1430
14. McNamara PJ, Sehgal A (2007) Towards rational management of patent ductus arteriosus: the need for disease staging. Arch Child Fetal Neonatal Ed 92:F424-F427
15. Mercanti I, Boubred F, Simeoni U (2009) Therapeutic closure of the ductus arteriosus: benefits and limitations. J Matern Fetal Neonatal 22(Suppl 3):14-20
16. Nuntnarumit P, Khositseth A, Thanomsingh P (2009) N-Terminal probrain natriuretic peptide and patent ductus arteriosus in preterm infants. J Perinatol 29:137-142
17. Ramakrishnan S, Heung YM, Round J, Morris TP, Collinson P, Williams AF (2009) Early N-terminal pro-brain natriuretic peptide measurements predict clinically significant ductus arteriosus in preterm infants. Acta Paediatr 98:1254-1259
18. Sehgal A, McNamara PJ (2009) Does echocardiography facilitate determination if hemodynamic significance attributable to ductus arteriosus? Eur J Pediatr 168:907-914
19. Skelton R, Evans N, Smythe J (1994) A blinded comparison of clinical and echocardiographical evaluation of the preterm infant for patent ductus arteriosus. J Paediatr Child Health 30:406-411